Abstract
Eltrombopag is indicated in patients with severe aplastic anemia (SAA) refractory to prior immunosuppressive therapy. The combination of eltrombopag and immunosuppressive therapy (such as cyclosporine) is currently being evaluated in patients with treatment-naive SAA. Cyclosporine is a human breast cancer resistance protein (BCRP) inhibitor, and can potentially alter plasma exposure to eltrombopag, a BCRP substrate. This phase 1, open-label, randomized, 3-period, crossover study evaluated the effect of cyclosporine on the pharmacokinetics of eltrombopag in healthy adults. Thirty-nine subjects were randomized to either single dose of eltrombopag 50 mg, cyclosporine 200 mg + eltrombopag 50 mg or cyclosporine 600 mg + eltrombopag 50 mg treatment groups. Eltrombopag pharmacokinetic parameters (Cmax, tmax, AUClast, AUCinf, %AUCex, t1/2, and CL/F) were determined using noncompartmental methods. Geometric mean AUCinf, AUClast, and Cmax, were decreased by 18, 20, and 25%, respectively, for cyclosporine 200 mg + eltrombopag and by 24, 22, and 39%, respectively, for cyclosporine 600 mg + eltrombopag groups compared to the eltrombopag alone group. The median tmax was prolonged by ~ 1 h in both coadministration treatments. The geometric me...Continue Reading
References
Feb 1, 1994·Pharmaceutical Research·E A MuellerK Kutz
Jul 13, 2000·European Journal of Drug Metabolism and Pharmacokinetics·P A KellyH W Strobel
Jan 13, 2006·Cancer Chemotherapy and Pharmacology·Anshul GuptaQingcheng Mao
Jan 16, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cindy Q XiaLiang-Shang Gan
Mar 1, 2007·Blood·Julian M JenkinsConnie L Erickson-Miller
Jan 8, 2008·The American Journal of Gastroenterology·Michael B SternthalDaniel H Present
Nov 29, 2008·Stem Cells·Connie L Erickson-MillerJulian M Jenkins
Feb 24, 2009·Lancet·James B BusselMichael Arning
May 19, 2009·Clinical Therapeutics·Daphne D WilliamsJulian M Jenkins
Sep 17, 2009·European Journal of Clinical Pharmacology·Julian JenkinsValerie S Kitchen
Jul 21, 2010·British Journal of Clinical Pharmacology·Gemma MatthysBin Peng
Jul 29, 2010·Journal of Clinical Pharmacology·Ekaterina GibianskyDaniele Ouellet
Mar 17, 2011·Journal of Clinical Pharmacology·Sam RebelloVenkateswar Jarugula
Mar 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kazuya TakeuchiYukio Kato
Mar 26, 2011·British Journal of Clinical Pharmacology·Alicia J AllredEdmund Lee
Mar 7, 2012·Antimicrobial Agents and Chemotherapy·Mary B WireBin Peng
May 1, 2012·Journal of Medicinal Chemistry·Maria KarlgrenPer Artursson
Dec 25, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert ElsbyKatherine Fenner
Apr 20, 2017·The New England Journal of Medicine·Danielle M TownsleyNeal S Young
Jun 28, 2018·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Daniel Valente NevesVera Lucia Lanchote